Literature DB >> 7035323

Effect of metoclopramide on plasma aldosterone in normal subjects, primary aldosteronism and hypopituitarism.

F Mantero, G Opocher, M Boscaro, E Valpione, D Armanini, F Fallo.   

Abstract

The behaviour of plasma renin, aldosterone, cortisol and prolactin after administration of a drug with antidopaminergic action, metoclopramide, was evaluated in 6 normal subjects, 8 patients affected by primary aldosteronism and in 5 patients affected by anterior hypopituitarism. In the first two groups, besides the predictable increase of prolactin under metoclopramide, a significant aldosterone increase was noted. Cortisol remained unchanged, and PRA was not significantly increased. A similar pattern of aldosterone, cortisol and PRA was also found in patients with hypopituitarism. However, the plasma prolactin did not increase in this group. The comparative examination of three groups of patients leads us to conclude that aldosterone increase is not imputable to ACTH, renin or to prolactin. This may be explained by a possible direct effect of the antidopaminergic drug at the adrenal level, which is more likely than an effect through some yet undetermined factor.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7035323     DOI: 10.1055/s-2007-1019302

Source DB:  PubMed          Journal:  Horm Metab Res        ISSN: 0018-5043            Impact factor:   2.936


  4 in total

1.  Effect of verapamil on aldosterone secretion in primary aldosteronism.

Authors:  G Opocher; S Rocco; A Murgia; F Mantero
Journal:  J Endocrinol Invest       Date:  1987-10       Impact factor: 4.256

Review 2.  Metoclopramide. An updated review of its pharmacological properties and clinical use.

Authors:  R A Harrington; C W Hamilton; R N Brogden; J A Linkewich; J A Romankiewicz; R C Heel
Journal:  Drugs       Date:  1983-05       Impact factor: 9.546

3.  Aldosterone suppression with dopamine infusion in low-renin hypertension.

Authors:  O B Holland; C Thomas; H Brown; D Schindewolf; Y Hillier; C Gomez-Sanchez
Journal:  J Clin Invest       Date:  1983-09       Impact factor: 14.808

4.  High prevalence of thyroid ultrasonographic abnormalities in primary aldosteronism.

Authors:  Decio Armanini; Davide Nacamulli; Carla Scaroni; Franco Lumachi; Riccardo Selice; Cristina Fiore; Gennaro Favia; Franco Mantero
Journal:  Endocrine       Date:  2003-11       Impact factor: 3.925

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.